Osteoporosis and Fragilty Fractures: An Overview.

dc.contributor.authorAslan, Ahmet
dc.date.accessioned2026-01-24T12:00:52Z
dc.date.available2026-01-24T12:00:52Z
dc.date.issued2022
dc.departmentAlanya Alaaddin Keykubat Üniversitesi
dc.description.abstractOsteoporosis (OP); It is a metabolic bone disease characterized by decreased bone mineral density (BMD) and bone strength, increased bone fragility and fracture risk, and deterioration in the microarchitecture of bone tissue. The most important cause of morbidity and mortality in OP are fragility fractures such as osteoporotic hip fractures. Prevention and treatment of osteoporosis can prevent hip fractures and comorbidities. In this paper, the available information about Osteoporosis and Osteoporotic fractures is briefly reviewed.
dc.identifier.endpage2
dc.identifier.issn2587-0319
dc.identifier.issue1
dc.identifier.startpage1
dc.identifier.trdizinid1119046
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1119046
dc.identifier.urihttps://hdl.handle.net/20.500.12868/3785
dc.identifier.volume6
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.relation.ispartofActa Medica Alanya
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_TR-Dizin_20260121
dc.subjectTreatment
dc.subjectOsteoporosis
dc.subjectbone mineral density
dc.subjectosteoporotic fractures
dc.subjectbisphosphonates
dc.titleOsteoporosis and Fragilty Fractures: An Overview.
dc.typeEditorial

Dosyalar